International Conference on Antiviral Strategies, Vaccines and Immunology (ICAVSI - 26)

This track focuses on the latest developments in antiviral therapies and strategies aimed at combating viral infections. Researchers are invited to present innovative approaches and novel compounds that demonstrate efficacy against a range of viruses.

This session will explore cutting-edge technologies and methodologies in vaccine design and production. Topics may include mRNA vaccines, vector-based vaccines, and novel adjuvants that enhance immune responses.

This track examines the immune mechanisms activated during viral infections and their implications for disease progression. Presentations will cover cellular and humoral responses, as well as the role of immune evasion by viruses.

This session focuses on the molecular and cellular mechanisms underlying viral pathogenesis. Researchers are encouraged to discuss the interplay between viral factors and host responses that contribute to disease severity.

This track addresses the epidemiological trends and patterns of infectious diseases globally. Presentations will highlight surveillance data, outbreak investigations, and the impact of social determinants on disease spread.

This session invites discussions on clinical trials and studies evaluating the safety and efficacy of antiviral treatments. Researchers will share insights on patient outcomes and challenges faced in clinical settings.